Northwell Health

BLR's EHS Daily Advisor honors the winners of the 2023 Safety Standout Awards for their dedication to safety and performance.

Retrieved on: 
Thursday, August 24, 2023
Communication, Siderian, Accident, BLR, Perception, Innovation, Huntington Hospital, VF Corporation, VF, Internet, The North Face, Kinetic, Risk, EH&S, AFO, Biophysical environment, EH, Injury, Culture, Robotics, Northwell Health, Family, Memory, CSP, EHS, Automation, Machine shop, Management, Nursing, Mudd, Safety, Health, Vans, Dickies

BRENTWOOD, Tenn., Aug. 24, 2023 /PRNewswire-PRWeb/ -- On August 21, 2023, during its EHS NOW virtual ceremony, BLR's EHS Daily Advisor extended congratulations to the winners of its annual Safety Standout Awards program for demonstrating steadfast commitment to workplace safety and compliance.

Key Points: 
  • On August 21, 2023, during its EHS NOW virtual ceremony, BLR's EHS Daily Advisor extended congratulations to the winners of its annual Safety Standout Awards program for demonstrating steadfast commitment to workplace safety and compliance.
  • BRENTWOOD, Tenn., Aug. 24, 2023 /PRNewswire-PRWeb/ -- On August 21, 2023, during its EHS NOW virtual ceremony, BLR's EHS Daily Advisor extended congratulations to the winners of its annual Safety Standout Awards program for demonstrating steadfast commitment to workplace safety and compliance.
  • Safety Standout Awards are given in the following six categories:
    Best Overall Safety Program and Culture: AT&T Field Operations
    AT&T Field Operations (AFO) created a national Environmental, Health, and Safety (EH&S) team focused on the EH&S concerns of its employees.
  • They deployed safety advocates and champions across the country to solely focus on safety conversations, best practices, and self-awareness.

Northwell brings transplant, primary care services to New Jersey

Retrieved on: 
Tuesday, August 22, 2023
General Health, Hospitals, Health, Practice Management, Managed Care, CMS, Chronic liver disease, Hepatology, Liver disease, Centers for Disease Control and Prevention, Multimedia, Northwell Health, U.S. News & World Report, Teaching hospital, North Shore University Hospital, Suite, MD, Patient, Death, News, Hospital, Dentistry

Northwell Health Physician Partners (NHPP) has begun offering primary care, specialty services and a focus on the full array of liver diseases in Edgewater, N.J.

Key Points: 
  • Northwell Health Physician Partners (NHPP) has begun offering primary care, specialty services and a focus on the full array of liver diseases in Edgewater, N.J.
  • View the full release here: https://www.businesswire.com/news/home/20230822758463/en/
    Dr. Nabil Dagher, vice president and director of the Northwell Transplant Institute, meets with a patient.
  • (Photo: Business Wire)
    The services include hepatology and liver transplant specialists through the Northwell Transplant Institute in Manhasset, N.Y.
  • “We’re excited to bring transplant services to northern New Jersey,” said Nabil Dagher, MD , vice president and director of the Northwell Transplant Institute.

Magenta Medical Completes Enrollment to Early Feasibility Study for World's Smallest Heart Pump

Retrieved on: 
Tuesday, August 22, 2023
Heart, Abdominal aortic aneurysm, Cardiogenic shock, Interventional cardiology, Aneurysm, Cardiac catheterization, Northwell Health, Splenic infarction, Quality of life, Nasiriyah Heart Center, Magenta, Artery, Federal, IVUS, Atherosclerosis, Teaching hospital, PCI, North Shore University Hospital, LAD, Mount Sinai Hospital, Patient, Risk, Elevate, St. Francis Hospital, Hospital, Coronary artery disease, FDA, Mount Sinai Health System, Groin, Safety, Pharmaceutical industry, Medical device, Nursing, Cardiology

KADIMA, Israel, Aug. 22, 2023 /PRNewswire/ -- Magenta Medical, developer of the world's smallest heart pump, announced today the completion of enrollment to its FDA-approved Early Feasibility Study with the Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) for the high-risk percutaneous coronary intervention (HR-PCI) indication. All 15 study patients were enrolled and successfully treated at Mount Sinai Hospital, St. Francis Hospital and Heart Center, and North Shore University Hospital. The Elevate™ Early Feasibility Study was approved by the FDA to evaluate the safety and feasibility of the Elevate™ System in providing temporary mechanical circulatory support during HR-PCI procedures, and constitutes the first step in a clinical program intended to secure approval for the device in the US for this indication.

Key Points: 
  • KADIMA, Israel, Aug. 22, 2023 /PRNewswire/ -- Magenta Medical , developer of the world's smallest heart pump, announced today the completion of enrollment to its FDA-approved Early Feasibility Study with the Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) for the high-risk percutaneous coronary intervention (HR-PCI) indication.
  • All 15 study patients were enrolled and successfully treated at Mount Sinai Hospital, St. Francis Hospital and Heart Center, and North Shore University Hospital.
  • "Having now used the system in nine complex, high-risk PCI cases, I can truly appreciate its advantages," said Dr. Sharma.
  • The percutaneous Elevate™ heart pump is inserted over a guidewire through commercially available 10 Fr introducer sheaths that require a small puncture in the groin.

Ascertain Announces Leadership Team With Appointment of CEO Mark Michalski, M.D. and Executive Chairman Gregg Fergus

Retrieved on: 
Tuesday, August 22, 2023
DNA, Plague, Partnership, Butterfly network, Stanford University, Medicine, CMO, Northwell Health, Patient, Mass, Yale University, AI, Research, Division of Program Coordination, Planning, and Strategic Initiatives, Therapy, Genome, Medical device, Management, Pharmaceutical industry, Nursing, Aegis, Amazon, Certificate of ascertainment

NEW YORK, Aug. 22, 2023 /PRNewswire/ -- Ascertain, a healthcare AI company creation platform, today announced the formation of its leadership team with the appointment of CEO Mark Michalski, M.D. and Executive Chairman, Gregg Fergus. Michalski and Fergus will lead Ascertain in its mission to merge deep technical, operational, and clinical expertise to deliver high-quality, equitable, and affordable healthcare.

Key Points: 
  • NEW YORK, Aug. 22, 2023 /PRNewswire/ -- Ascertain, a healthcare AI company creation platform, today announced the formation of its leadership team with the appointment of CEO Mark Michalski, M.D.
  • Michalski and Fergus will lead Ascertain in its mission to merge deep technical, operational, and clinical expertise to deliver high-quality, equitable, and affordable healthcare.
  • Michalski brings two decades of executive leadership experience to Ascertain.
  • This expansion of its leadership team is part of Ascertain's ongoing efforts to build a world-class, interdisciplinary AI team to create and support its portfolio companies.

Firearms deaths among U.S. children continue to spike, Northwell Health study shows over 40 percent increase

Retrieved on: 
Monday, August 21, 2023
Other Health, Research, Men, General Health, Consumer, Hospitals, Parenting, Children, Science, Women, Other Science, Health, Elmezzi Graduate School of Molecular Medicine, Poverty, Male, Gun violence in the United States, Pediatrics, Violence, Accident, Feinstein Institutes for Medical Research, Hospital, Gun violence, Homicide, Multimedia, Northwell Health, Black, Firearm death rates in the United States by state, Person, Firearm, CDC, Death, WONDER, MD, Patient, Risk, Child, Korea Disease Control and Prevention Agency, Cohen, General surgery, Ageing, Geography, Trauma, Credit, Medical research, Injury, Birth control, Nursing, Drug

New research, led by Northwell Health and the Feinstein Institutes for Medical Research , found a 41.6 percent increase in the firearm death rate among children and adolescents between 2018-2021.

Key Points: 
  • New research, led by Northwell Health and the Feinstein Institutes for Medical Research , found a 41.6 percent increase in the firearm death rate among children and adolescents between 2018-2021.
  • View the full release here: https://www.businesswire.com/news/home/20230821043754/en/
    Dr. Chethan Sathya is the director of Northwell Health’s Center for Gun Violence Prevention.
  • The paper, titled “Trends and Disparities in Firearm Deaths among Children,” showed: From 2018-2021, there was a 41.6 percent increase in the firearm death rate.
  • The time to act is long overdue.”
    Since 2019, Northwell Health has been leading the charge to address gun violence as a public health crisis.

Northwell Health Summer Hamptons Evening event raises $1M for women’s health research and programs

Retrieved on: 
Thursday, August 17, 2023
Managed Care, General Health, Entertainment, Events, Concerts, Philanthropy, Consumer, Celebrity, Fund Raising, Foundation, Music, Women, Other Philanthropy, Health, Forever Summer: Hamptons, Christie, P.C, 77th Street, Cancer, Woman, DRS, Breast, Multimedia, Research, SHE, Lenox Hill Hospital, Estate (law), Hospital, Impossible, MD, Patient, Risk, Ruth, Cosmetics, Cori, Personality, Diagnosis, News, Dietary supplement, Pharmaceutical industry, Northwell Health

Music superstar and renowned dancer, choreographer and TV personality Paula Abdul performed at Northwell Health’s fifth annual Summer Hamptons Evening (SHE) on August 12, which raised $1 million for the Katz Institute for Women’s Health .

Key Points: 
  • Music superstar and renowned dancer, choreographer and TV personality Paula Abdul performed at Northwell Health’s fifth annual Summer Hamptons Evening (SHE) on August 12, which raised $1 million for the Katz Institute for Women’s Health .
  • View the full release here: https://www.businesswire.com/news/home/20230817788107/en/
    Supporters of the event are raising health for the women in the communities Northwell serves.
  • The campaign’s objectives include improving hospitals and clinical programs, accelerating research and funding endowment.
  • For more information about supporting the Katz Institute for Women’s Health and Northwell Health, visit northwell.edu/katz-institute-for-womens-health

Food and Drug Administration Approves First Postpartum Depression Pill, Research Led by Northwell Health’s Feinstein Institutes

Retrieved on: 
Monday, August 7, 2023
Women, Biotechnology, Pharmaceutical, Health, FDA, Mental Health, Consumer, Clinical Trials, GABA, PPD, Medicine, JAMA, NAS, Feinstein Institutes for Medical Research, Neurochemistry, Woman, Multimedia, Research, Northwell Health, The American Journal of Psychiatry, Bangladesh Technical Education Board, American Medical Association, American Journal, Behavioural sciences, Journal, Patient, Zuranolone, Grammatical mood, Psychiatry, Credit, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, NIH, Medical research, Food, Safety, Allopregnanolone, Pharmaceutical industry, MD

View the full release here: https://www.businesswire.com/news/home/20230807136425/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230807136425/en/
    The national clinical trials for zuranolone were led by the Feinstein Institutes for Medical Research at Northwell Health.
  • “After years of dedicated research and collaboration with other scientists, women living with postpartum depression have a new, at-home, 14-day treatment option that has the potential to alleviate their symptoms,” said Dr. Deligiannidis.
  • Deligiannidis is a leader in clinical trials for postpartum depression, a condition that affects millions,” said Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes, Karches Family Distinguished Chair in Medical Research.
  • “The FDA approval stemming from her work will make available new therapeutic options that are clearly needed.”
    The Feinstein Institutes and Dr. Deligiannidis lead in researching new methods to diagnose and treat perinatal depression.

New study shows that WATS3D increases diagnostic yield of dysplasia in Barrett's esophagus, regardless of segment length

Retrieved on: 
Wednesday, August 2, 2023
Male, ASGE, University, Diagnosis, Barrett's esophagus, American Society for Gastrointestinal Endoscopy, Pathology, Intestinal metaplasia, Gastrointestinal Endoscopy, MBA, University of Rochester Medical Center, Consultant, Nature Reviews Gastroenterology & Hepatology, Gastrointestinal tract, Dysplasia, Hepatology, Patient, Division, Gastroenterology, GIE, Epithelium, Northwell Health, Society, Medical device, Endoscopy, MD, Fellowship of the Royal Colleges of Surgeons

Regardless of segment length, WATS3D is highly effective at increasing the diagnostic yield of intestinal metaplasia and dysplasia.

Key Points: 
  • Regardless of segment length, WATS3D is highly effective at increasing the diagnostic yield of intestinal metaplasia and dysplasia.
  • "WATS3D has previously shown diagnostic effectiveness for patients with known or suspected BE," said the lead author of the study, Dr. Arvind Trindade, Regional Director of Endoscopy, Northwell Health.
  • "This new study focuses on WATS3D performance in short versus long segment esophageal columnar-lined mucosa."
  • The adjunctive and absolute yields of WATS3D were calculated according to the length of the patient's BE segment.

Northwell Health is New York’s most awarded health system by U.S. News

Retrieved on: 
Tuesday, August 1, 2023
Health, Hospitals, Heart, Endocrinology, Obstetrics, Diabetes, Nursing, Elective surgery, Hospital, Multimedia, Gynaecology, Huntington Hospital, U.S. News & World Report Best Hospitals Rankings, U.S. News & World Report, Teaching hospital, Nose, North Shore University Hospital, Long Island Jewish Medical Center, Lenox Hill Hospital, Plainview Hospital, Lenox Hill, Neurosurgery, Patient, Gastroenterology, Neurology, GI, LIJ, Ear, News, Dentistry, Orthopedic surgery, Northwell Health, Cancer, Urology, Geriatrics

Two other Northwell hospitals also placed in the top 10 in state rankings, and dozens of programs across the health system were also ranked incredibly well.

Key Points: 
  • Two other Northwell hospitals also placed in the top 10 in state rankings, and dozens of programs across the health system were also ranked incredibly well.
  • View the full release here: https://www.businesswire.com/news/home/20230801769477/en/
    Dozens of Northwell specialty programs were ranked among the best in the nation by U.S. News & World Report.
  • “We are proud to see Northwell recognized as New York State’s most-awarded health system.
  • The health system has more hospitals ranked as the top in the state, and has more specialties ranked nationally as well.

For the First Time Bioelectronic Medicine Researchers at The Feinstein Institutes Restore Feeling and Lasting Movement in Man Living With Quadriplegia

Retrieved on: 
Friday, July 28, 2023
Science, Neurology, Biotechnology, Research, Surgery, Health, Health Technology, Clinical Trials, Medicine, Disease, Surgeon, Arm, Clinical trial, Diabetes, Wrist, Inflammatory Bowel Diseases, Arthritis, Spinal cord, Interface (computing), Feinstein Institutes for Medical Research, Cancer, Spine, Hope, Brain, Multimedia, Rehabilitation, Biomedical engineering, Sensation, Doctor of Philosophy, Inflammation, Movement, Computer, Northwell Health, Paralysis, North Shore University Hospital, Crohn's disease, Neuroscience, Magnetic resonance imaging, C4, MD, Laboratory, Algorithm, Nervous system, Outline of brain mapping, C5, Kidney, Feinstein, Brain mapping, Artificial intelligence, Injury, System, Pulmonary hypertension, Trauma, Molecular medicine, Hand, Credit, Medical research, Forearm, Medical imaging, Pharmaceutical industry, Nursing

This clinical trial aims to restore lasting physical movement – outside of the research lab – and re-establish the sense of touch.

Key Points: 
  • This clinical trial aims to restore lasting physical movement – outside of the research lab – and re-establish the sense of touch.
  • The Feinstein Institutes for Medical Research is the global scientific home of bioelectronic medicine, which combines molecular medicine, neuroscience and biomedical engineering.
  • At the Feinstein Institutes, medical researchers use modern technology to develop new device-based therapies to treat disease and injury.
  • By producing bioelectronic medicine knowledge, disease and injury could one day be treated with our own nerves without costly and potentially harmful pharmaceuticals.